Data as of Mar 14
| +0.02 / +0.16%|
The 15 analysts offering 12-month price forecasts for Ironwood Pharmaceuticals Inc have a median target of 16.00, with a high estimate of 25.00 and a low estimate of 9.00. The median estimate represents a +25.59% increase from the last price of 12.74.
The current consensus among 15 polled investment analysts is to Buy stock in Ironwood Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.